Successful infliximab therapy in a patient with comorbid spondyloarthritis, primary biliary cirrhosis and generalized morphea.
Acta Clin Belg
; 72(5): 365-368, 2017 Oct.
Article
em En
| MEDLINE
| ID: mdl-28229620
ABSTRACT
The patient in this report was diagnosed simultaneously with primary biliary cirrhosis (PBC), spondyloarthritis, and generalized morphea and was started on infliximab therapy. In addition to an improvement in clinical symptoms with this therapy, an improvement was also observed in laboratory parameters such as cholestatic enzymes, C-reactive protein, and erythrocyte sedimentation rate. Infliximab was well tolerated in this 56-year-old patient. However, further studies must be performed in order to clarify the therapeutic role of TNF-α blockers in, PBC and generalized morphea.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esclerodermia Localizada
/
Antirreumáticos
/
Espondilartrite
/
Infliximab
/
Cirrose Hepática Biliar
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Acta Clin Belg
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Turquia